ENTRY       D08605                      Drug
NAME        Tipranavir (INN);
            Aptivus (TN)
PRODUCT     APTIVUS (Boehringer Ingelheim Pharmaceuticals)
FORMULA     C31H33F3N2O5S
EXACT_MASS  602.2062
MOL_WEIGHT  602.6643
CLASS       Antiviral
             DG03107  Anti-HIV agent
              DG01647  HIV protease inhibitor
REMARK      ATC code: J05AE09
            Chemical structure group: DG00658
            Product (DG00658): D08605<US>
EFFICACY    Antiviral, HIV protease inhibitor
  DISEASE   HIV-1 infection [DS:H01563]
COMMENT     Nonpeptidic
TARGET      HIV protease [KO:K22599]
  PATHWAY   ko03230(K22599)  Viral genome structure
            ko03250(K22599)  Viral life cycle - HIV-1
INTERACTION  
STR_MAP     map07053  Anti-HIV agents
            map07218  HIV protease inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AE Protease inhibitors
                 J05AE09 Tipranavir
                  D08605  Tipranavir (INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Agents, Protease Inhibitors (PI)
               Tipranavir
                D08605  Tipranavir (INN)
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               DG01647  HIV protease inhibitor
                DG00658  Tipranavir
                 D08605  Tipranavir
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D08605  Tipranavir
            Antimicrobials [BR:br08307]
             Antivirals
              Polyprotein cleavage inhibitor
               HIV protease inhibitor
                D08605  Tipranavir (INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D08605
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D08605
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D08605
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               DG01647  HIV protease inhibitor
                DG00658  Tipranavir
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Polyprotein cleavage inhibitor
               HIV protease inhibitor
                DG00658  Tipranavir
DBLINKS     CAS: 174484-41-4
            PubChem: 96025289
            ChEBI: 63628
            PDB-CCD: TPV
            LigandBox: D08605
ATOM        42
            1   C8x C    18.7600  -21.1400
            2   C8y C    18.7600  -19.7400
            3   N5x N    17.5700  -19.0400
            4   C8x C    16.3100  -19.7400
            5   C8y C    16.3100  -21.1400
            6   C8x C    17.5700  -21.8400
            7   C1d C    15.1200  -21.8400
            8   X   F    13.8600  -22.5400
            9   X   F    14.4200  -20.6500
            10  X   F    15.8200  -23.0300
            11  S4a S    19.9500  -19.0400
            12  N1b N    21.1400  -19.7400
            13  O3c O    20.9300  -18.0600
            14  O3c O    18.9700  -18.0600
            15  C8y C    22.3300  -19.0400
            16  C8x C    23.5200  -19.7400
            17  C8y C    24.7800  -19.0400
            18  C8x C    24.7800  -17.6400
            19  C8x C    23.5900  -16.9400
            20  C8x C    22.3300  -17.6400
            21  C1c C    25.9700  -19.7400
            22  C2y C    27.2300  -19.0400
            23  C7x C    28.3500  -19.7400
            24  O7x O    29.6100  -19.0400
            25  C1z C    29.6100  -17.6400
            26  C1x C    28.3500  -16.9400
            27  C2y C    27.2300  -17.6400
            28  C8y C    32.4100  -15.2600
            29  C8x C    33.8100  -15.2600
            30  C8x C    34.5100  -14.0700
            31  C8x C    33.8100  -12.8100
            32  C8x C    32.4100  -12.8100
            33  C8x C    31.7100  -14.0700
            34  C1b C    31.7100  -16.4500
            35  C1b C    30.3100  -16.4500
            36  C1b C    31.0100  -17.6400
            37  C1b C    31.7100  -18.8300
            38  C1a C    33.1100  -18.8300
            39  O6a O    28.3500  -21.1400
            40  O1a O    26.0400  -16.9400
            41  C1b C    25.9700  -21.1400
            42  C1a C    24.7100  -21.8400
BOND        45
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     7   9 1
            10    7  10 1
            11    2  11 1
            12   11  12 1
            13   11  13 2
            14   11  14 2
            15   12  15 1
            16   15  16 2
            17   16  17 1
            18   17  18 2
            19   18  19 1
            20   19  20 2
            21   15  20 1
            22   17  21 1
            23   21  22 1
            24   22  23 1
            25   23  24 1
            26   24  25 1
            27   25  26 1
            28   26  27 1
            29   22  27 2
            30   28  29 2
            31   29  30 1
            32   30  31 2
            33   31  32 1
            34   32  33 2
            35   28  33 1
            36   28  34 1
            37   34  35 1
            38   25  35 1 #Up
            39   25  36 1 #Down
            40   36  37 1
            41   37  38 1
            42   23  39 2
            43   27  40 1
            44   21  41 1 #Down
            45   41  42 1
///
